SLAMF7 antibody (C-Term)
Quick Overview for SLAMF7 antibody (C-Term) (ABIN8037959)
Target
See all SLAMF7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- Anti-CD319/SLAMF7 Antibody
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins
-
Characteristics
- Anti-CD319/SLAMF7 Antibody. Tested in WB applications. This antibody reacts with Human, Mouse, Rat.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of human CD319/SLAMF7.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Concentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for six months. Avoid repeated freezing and thawing. -
Expiry Date
- 12 months
-
-
- SLAMF7 (SLAM Family Member 7 (SLAMF7))
-
Alternative Name
- SLAMF7
-
Background
-
Background: Enables identical protein binding activity. Predicted to be involved in T cell activation and immune response. Predicted to act upstream of or within regulation of natural killer cell activation. Located in endoplasmic reticulum.
Gene Full Name: SLAM family member 7
-
Molecular Weight
- 70 kDa
-
Gene ID
- 57823
-
UniProt
- Q9NQ25
Target
-